Integra LifeSciences Holdings (IART)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 1,395,820 1,419,620 1,333,410 1,337,210 1,300,490 1,381,140 1,385,540 1,389,930 1,388,680 1,387,430 1,386,180 1,484,910 1,408,220 1,414,000 1,472,320 1,478,190 1,198,560 1,274,050 1,204,540 1,205,020
Total stockholders’ equity US$ in thousands 1,587,880 1,579,220 1,683,160 1,674,940 1,804,400 1,724,410 1,660,920 1,615,200 1,684,800 1,631,690 1,574,980 1,529,330 1,514,870 1,397,990 1,349,100 1,341,800 1,416,740 1,384,970 1,420,950 1,397,030
Debt-to-capital ratio 0.47 0.47 0.44 0.44 0.42 0.44 0.45 0.46 0.45 0.46 0.47 0.49 0.48 0.50 0.52 0.52 0.46 0.48 0.46 0.46

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,395,820K ÷ ($1,395,820K + $1,587,880K)
= 0.47

The debt-to-capital ratio of Integra Lifesciences Holdings Corp has been relatively stable over the past few quarters, ranging between 0.44 and 0.49. This ratio indicates that the company relies on debt to finance a significant portion of its capital structure, with debt representing a range of 44% to 49% of the company's total capital.

The stability of the ratio suggests that the company has been managing its debt levels consistently over time. A higher debt-to-capital ratio may indicate increased financial risk due to higher leverage, potentially leading to higher interest payments and financial difficulty in case of economic downturns. Conversely, a lower ratio indicates a lower reliance on debt financing and potentially lower financial risk.

It would be beneficial for stakeholders to monitor any changes in Integra Lifesciences Holdings Corp's debt-to-capital ratio in future quarters to assess the company's financial health and risk profile.


Peer comparison

Dec 31, 2023